Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer

Clinical trial NCT01934478 · COMPLETED

Trial details

NCT number: NCT01934478
Sponsor: Qingdao Central Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Start date: 2013-08-01
Primary completion: 2022-12-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.